Showing Our Gratitude: Addressing COVID-19 Takes a Global Effort

We can’t do it alone. That’s why we’re saying a huge thank you.
Jan 5, 2022 8:20 AM ET

Taking on COVID-19 isn’t just a team effort — it’s also a global one. Here at Merck, we’re grateful to all the people who have worked hard to keep us safe, along with everyone around the world helping to combat the pandemic.

That’s why we’re saying thank you!

Watch as our colleagues share heartfelt messages of thanks to the researchers, scientists, clinical trial participants, our global partners and everyone else who’s played such an important role throughout the COVID-19 pandemic and advancing our mission to help save and improve lives.  

About Merck
For more than a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.

View the original content here.